{{Distinguish|Pipamperone}}
{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one
| image = 
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 75444-65-4
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 4847
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 4681
| UNII = Y9FMC4513X
| KEGG = D05495
| ChEBI = 92444
| ChEMBL = 18331
| synonyms = R-47456; R-50656

<!--Chemical data-->
| C=23 | H=24 | F=1 | N=3 | O=2
| molecular_weight = 393.462 g/mol
| SMILES = CC1=C(C(=O)N2C=CC=CC2=N1)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F
| StdInChI_Ref = 
| StdInChI = 1S/C23H24FN3O2/c1-16-20(23(29)27-12-3-2-4-21(27)25-16)11-15-26-13-9-18(10-14-26)22(28)17-5-7-19(24)8-6-17/h2-8,12,18H,9-11,13-15H2,1H3
| StdInChIKey_Ref = 
| StdInChIKey = HXCNRYXBZNHDNE-UHFFFAOYSA-N
}}

'''Pirenperone''' ({{abbrlink|INN|International Nonproprietary Name}}, {{abbrlink|USAN|United States Adopted Name}}, {{abbrlink|BAN|British Approved Name}}; developmental code names '''R-47456''', '''R-50656''') is a [[serotonin receptor antagonist]] described as an [[antipsychotic]] and [[tranquilizer]] which was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA994|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=994–}}</ref><ref name="MortonHall1999">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=mqaOMOtk61IC&pg=PA223|date=31 October 1999|publisher=Springer Science & Business Media|isbn=978-0-7514-0499-9|pages=223–}}</ref> It is a relatively [[binding selectivity|selective]] [[receptor antagonist|antagonist]] of the [[serotonin receptor|serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]]s and has been used in [[scientific research]] to study the [[serotonin]] system.<ref name="MortonHall1999" /><ref name="ColpaertBalster2012">{{cite book|author1=Francis C. Colpaert|author2=Robert Balster|title=Transduction Mechanisms of Drug Stimuli|url=https://books.google.com/books?id=9PfRBgAAQBAJ&pg=PT29|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-73223-2|pages=29–}}</ref> In the 1980s, the drug was found to block the effects of the [[lysergic acid diethylamide]] (LSD) in animals, and along with [[ketanserin]], led to the elucidation of the [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]] as the [[biological target|biological mediator]] of the effects of serotonergic psychedelics.<ref name="pmid26841800">{{cite journal | vauthors = Nichols DE | title = Psychedelics | journal = Pharmacol. Rev. | volume = 68 | issue = 2 | pages = 264–355 | year = 2016 | pmid = 26841800 | pmc = 4813425 | doi = 10.1124/pr.115.011478 | url = }}</ref>

==References==
{{Reflist|2}}


{{Serotonin receptor modulators}}

[[Category:5-HT2 antagonists]]
[[Category:Antipsychotics]]
[[Category:Anxiolytics]]
[[Category:Fluoroarenes]]
[[Category:Ketones]]
[[Category:Piperidines]]
[[Category:Pyridopyrimidines]]


{{Nervous-system-drug-stub}}